News 2011
The Accidental Activist
I stood in the huddle during a time-out of a vicious basketball battle against a rival high school as the coach told us that the game-winning shot should go to our team captain. Once the time-out was over, I in-bounded the ball to her. Our captain was heavily guarded yet ran the play. When she realized that I was wide open and had the better shot, she passed the ball back to me. As the clock wound down, I looked at the basket, then I passed the ball right back to her. Before she caught my pass, the clock ran out. They won. I'd blown the game.
Living With HIV Video: A Way to Educate Patients and Provide Support
The Ryan White HIV/AIDS Program is the largest Federal program devoted to a single disease. Every year more than half a million people living with HIV/AIDS in the United States receive treatment. That is the foundation from which our Program is built. The involvement of the HIV/AIDS community continues to be central to our success over the last twenty-plus years of our Program’s history.
Read more: Living With HIV Video: A Way to Educate Patients and Provide Support
Federal Efforts Build Momentum To Address Health Inequities -- Guest Opinion
During the month of April -- Minority Health Month -- the Obama administration took significant steps to build momentum for efforts to eliminate racial and ethnic health inequities. But with this momentum the stakes have become higher than ever, just as fiscal and political pressures mount that could undermine progress.
Read more: Federal Efforts Build Momentum To Address Health Inequities -- Guest Opinion
At Least 600,000 Young Adults Join Parents’ Health Plans Under New Law
Hundreds of thousands of young adults are taking advantage of the health care law provision that allows people under 26 to remain on their parents' health plans, some of the nation's largest insurers are reporting. That pace appears to be faster than the government expected.
Read more: At Least 600,000 Young Adults Join Parents’ Health Plans Under New Law
Immune-based therapies - an alternative to PrEP with HAART drugs?
The early termination of the FEM-PrEP trial was disappointing, but PrEP using antiviral drugs is not the only prevention game in town. NAPWA supports development of therapeutic vaccines and other immune-based therapies enabling people living with HIV to control their virus with less use of antiviral drugs. And the same immune-based therapies that may someday help infected people live healthy lives without drugs might, just might, also give uninfected people some protection from infection. We hosted a Community Forum on immune-based therapies in development at last summer's IAS conference in Vienna, and we are moving forward with plans to hold a second community forum on emerging but underfunded HIV therapies, focusing on potential next-generation breakthroughs, at this summer's IAS Pathogenesis Conference in Rome.
Read more: Immune-based therapies - an alternative to PrEP with HAART drugs?